Integrated serum proteomic and metabolomic profiling prioritises CSF-1 and PD-L1 as candidate circulating biomarkers associated with lupus nephritis: a two-stage cross-sectional study

Background Lupus nephritis (LN) contributes substantially to morbidity in systemic lupus erythematosus (SLE), but routine clinical and serological markers incompletely characterise renal involvement. We integrated serum inflammatory proteomics and metabolomics to identify LN-associated protein candidates and assess selected proteins by ELISA. Methods This single-centre cross-sectional study included a discovery cohort (n = 73; 22 healthy controls [HCs], 22 non-renal SLE, 29 LN) and an ELISA follow-up cohort (n = 79; 28 HCs, 25 non-renal SLE, 26 LN). Discovery sera underwent Olink Target 96 Inflammation profiling and untargeted metabolomics. Differential abundance and weighted gene co-expression network analyses prioritised candidates for ELISA. Discrimination and clinical associations were assessed by receiver operating characteristic and Spearman correlation analyses; public single-cell datasets were explored for candidate-gene expression. Results Four proteins were prioritised: CSF-1, PD-L1, CX3CL1, and SULT1A1. In the discovery cohort, AUCs for LN versus non-renal SLE were 0.857, 0.738, 0.784, and 0.743, respectively. In the follow-up cohort, CSF-1 and PD-L1 were elevated in LN, with AUCs of 0.890 (95% CI, 0.795–0.986) and 0.883 (0.791–0.975); CX3CL1 and SULT1A1 showed weaker discrimination. CSF-1 correlated with 24-hour urinary protein excretion in both cohorts (Spearman’s ρ = 0.768 and 0.687). No candidate consistently outperformed C3 or C4. Four metabolomic pathways remained significant after Holm correction; taurine was higher in LN than in both comparison groups. Exploratory single-cell analyses showed candidate-gene transcripts across renal and immune populations. Conclusions CSF-1 and PD-L1 are circulating candidates associated with LN, although their renal specificity and incremental clinical value require prospective evaluation.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11629375/v1
Primary Topic
Systemic Lupus Erythematosus Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrated serum proteomic and metabolomic profiling prioritises CSF-1 and PD-L1 as candidate circulating biomarkers associated with lupus nephritis: a two-stage cross-sectional study

王忠誉, wenjing liu, Shiting Xie, Yue Tao et al.
4 links
Research Square
Systemic Lupus Erythematosus Research
preprint

Integrated serum proteomic and metabolomic profiling prioritises CSF-1 and PD-L1 as candidate circulating biomarkers associated with lupus nephritis: a two-stage cross-sectional study

王忠誉, wenjing liu, Shiting Xie, Yue Tao, Haihui Xing, Fei Chen, Ping Yang, Zhiyang Li, Tiancheng Li
preprint en

Abstract

Background Lupus nephritis (LN) contributes substantially to morbidity in systemic lupus erythematosus (SLE), but routine clinical and serological markers incompletely characterise renal involvement. We integrated serum inflammatory proteomics and metabolomics to identify LN-associated protein candidates and assess selected proteins by ELISA. Methods This single-centre cross-sectional study included a discovery cohort (n = 73; 22 healthy controls [HCs], 22 non-renal SLE, 29 LN) and an ELISA follow-up cohort (n = 79; 28 HCs, 25 non-renal SLE, 26 LN). Discovery sera underwent Olink Target 96 Inflammation profiling and untargeted metabolomics. Differential abundance and weighted gene co-expression network analyses prioritised candidates for ELISA. Discrimination and clinical associations were assessed by receiver operating characteristic and Spearman correlation analyses; public single-cell datasets were explored for candidate-gene expression. Results Four proteins were prioritised: CSF-1, PD-L1, CX3CL1, and SULT1A1. In the discovery cohort, AUCs for LN versus non-renal SLE were 0.857, 0.738, 0.784, and 0.743, respectively. In the follow-up cohort, CSF-1 and PD-L1 were elevated in LN, with AUCs of 0.890 (95% CI, 0.795–0.986) and 0.883 (0.791–0.975); CX3CL1 and SULT1A1 showed weaker discrimination. CSF-1 correlated with 24-hour urinary protein excretion in both cohorts (Spearman’s ρ = 0.768 and 0.687). No candidate consistently outperformed C3 or C4. Four metabolomic pathways remained significant after Holm correction; taurine was higher in LN than in both comparison groups. Exploratory single-cell analyses showed candidate-gene transcripts across renal and immune populations. Conclusions CSF-1 and PD-L1 are circulating candidates associated with LN, although their renal specificity and incremental clinical value require prospective evaluation.

Research Square
Nanjing Normal University (CN), Nanjing Traditional Chinese Medicine Hospital (CN), Nanjing Drum Tower Hospital (CN), Gaochun People's Hospital (CN)
Nanjing University, Nanjing Drum Tower Hospital
Good health and well-being
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon